TABLE OF CONTENTS 1. INTRODUCTION 1.1. OVERVIEW OF THE EUROPE SPIROMETER MARKET 1.2. CURRENCY AND PRICING 1.3. LIMITATION 1.4. MARKETS COVERED 2 MARKET SEGMENTATION 2.1. KEY TAKEAWAYS 2.2. ARRIVING AT THE EUROPE SPIROMETER MARKET SIZE 2.2.1 VENDOR POSITIONING GRID 2.2.2 TECHNOLOGY LIFE LINE CURVE 2.2.3 MARKET TIME LINE 2.2.4 MARKET GUIDE 2.2.5 COMPANY POSITIONING GRID 2.2.6 COMAPANY MARKET SHARE ANALYSIS 2.2.7 MULTIVARIATE MODELLING 2.2.8 STANDARDS OF MEASUREMENT 2.2.9 TOP TO BOTTOM ANALYSIS 2.2.10 VENDOR SHARE ANALYSIS 2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS 2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES 2.3. EUROPE SPIROMETER MARKET: RESEARCH SNAPSHOT 2.4. ASSUMPTIONS   3 MARKET OVERVIEW 3.1. DRIVERS 3.1.1. RISING INCIDENCE OF RESPIRATORY DISEASES 3.1.2. TECHNOLOGICAL ADVANCEMENTS IN RESPIRATORY DEVICES 3.1.3. INCREASED DEMAND OF HOMECARE SETTING DEVICES 3.2. RESTRAINTS 3.2.1. WEAK REIMBURSEMENT POLICIES 3.3. OPPORTUNITIES 3.3.1. TECHNOLOGY DRIVING THE MARKET PROVIDES OPPURTUNITY TO UPCOMING PLAYERS 3.3.2. GOVERNMENT INITIATIVES TO CREATE AWARNESS REGARDING RESPIRATORY DISEASES AND ITS TREATMENT 3.4. CHALLENGES 3.4.1. LACK OF TRAINED PROFESSIONALS FOR SUPERVISING HIGH QUALITY SPIROMETERS 4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 5.1. EPIDEMIOLOGY STATISTICS OF CHRONIC OBSTRUCTIVE LUNG DISEASE 5.2. POPULATION DATA STATISTICS OF DIFFERENT TYPES OF RESPIRATORY DISEASES 5.3. VENDOR POSITIONING GRID AND INVESTMENT OPPURTUNITIES 5.4. TECHNOLOLGICAL ADVANCEMENTS 5.5. REIMBURSEMENT RATES 5.6. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE EUROPE SPIROMETER MARKET 5.7. MARKET REGULATORY SCENARIO 5.8. INTERVIEW KEY INSIGHTS   6 EUROPE SPIROMETER MARKET, BY PRODUCT TYPE 6.1. OVERVIEW 6.2. TABLE-TOP SPIROMETER 6.3. HAND-HELD SPIROMETER 6.4. DESKTOP SPIROMETER 7 EUROPE SPIROMETER MARKET, BY TECHNOLOGY 7.1. OVERVIEW 7.2. VOLUME MEASUREMENT SPIROMETER 7.2.1 WET SPIROMETERS 7.2.2. DRY SPIROMETERS 7.3. FLOW MEASUREMENT SPIROMETER 7.3.1 PNEUMO-TACHOGRAPH SYSTEMS 7.3.2. MASS FLOW METERS 7.4. PEAK FLOW METER 7.5. OTHERS 8 EUROPE SPIROMETER MARKET, BY DISEASE 8.1. OVERVIEW 8.2. ASTHMA 8.3. BRONCHITIS 8.4. EMPHYSEMA 8.5. CHRONIC OBSTRUCTIVE LUNG DISEASE 8.6. LUNG CANCER 8.7. OTHERS 9 EUROPE SPIROMETER MARKET, BY DISPOSABLE COMPONENTS 9.1. OVERVIEW 9.2. FILTERS 9.3. SENSORS 9.4. TUBES 10 EUROPE SPIROMETER MARKET, BY APPLICATION 10.1. OVERVIEW 10.2. DIAGNOSTICS 10.3. THERAPEUTIC 11 EUROPE SPIROMETER MARKET, BY END-USER 11.1. OVERVIEW 11.2. HOSPITALS 11.3. CLINICS 11.4. HOMECARE 12 EUROPE SPIROMETER MARKET, BY DISTRIBUTION CHANNEL 12.1. OVERVIEW 12.2. OVER THE COUNTER 12.3. DIRECT TENDER 13 EUROPE SPIROMETER MARKET: COMPETITIVE LANDSCAPE 13.1. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS 13.2. MERGERS & ACQUISITIONS 13.3. NEW PRODUCT DEVELOPMENT & APPROVALS 13.4. EXPANSIONS 13.5. REGULATORY CHANGES 13.6. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 14 EUROPE SPIROMETER MARKET, COMPANY PROFILES 14.1 WELCH ALLYN 14.1.1 COMPANY OVERVIEW 14.1.2. FINANCIAL ANALYSIS 14.1.3. PRODUCT MATRIX 14.1.4 RECENT DEVELOPMENTS 14.1.5. DATABRIDGE ANALYSIS   14.2 MIDMARK CORP. 14.2.1. COMPANY OVERVIEW 14.2.2 FINANCIAL ANALYSIS 14.2.3 PRODUCT MATRIX 14.2.4. RECENT DEVELOPMENTS 14.2.5. DATABRIDGE ANALYSIS 14.3 FUTUREMED 14.3.1. COMPANY OVERVIEW 14.3.2. FINANCIAL ANALYSIS 14.3.3. PRODUCT MATRIX 14.3.4. RECENT DEVELOPMENTS 14.3.5. DATABRIDGE ANALYSIS 14.4 COSMED 14.4.1. COMPANY OVERVIEW 14.4.2. FINANCIAL ANALYSIS 14.4.3. PRODUCT MATRIX 14.4.4. RECENT DEVELOPMENTS 14.4.5. DATABRIDGE ANALYSIS 14.5 MGC DIAGNOSTICS CORPORATION 14.5.1. COMPANY OVERVIEW 14.5.2. FINANCIAL ANALYSIS 14.5.3. PRODUCT MATRIX 14.5.4. RECENT DEVELOPMENTS 14.5.5. DATABRIDGE ANALYSIS   14.6 NIHON KOHDEN CORPORATION 14.6.1. COMPANY OVERVIEW 14.6.2. FINANCIAL ANALYSIS 14.6.3. PRODUCT MATRIX 14.6.4. RECENT DEVELOPMENTS 14.6.5. DATABRIDGE ANALYSIS 14.7 CHEST M.I., INC 14.7.1. COMPANY OVERVIEW 14.7.2. FINANCIAL ANALYSIS 14.7.3. PRODUCT MATRIX 14.7.4. RECENT DEVELOPMENTS 14.7.5. DATABRIDGE ANALYSIS 14.8 MEDICAL INTERNATIONAL RESEARCH 14.8.1. COMPANY OVERVIEW 14.8.2. FINANCIAL ANALYSIS 14.8.3. PRODUCT MATRIX 14.8.4. RECENT DEVELOPMENTS 14.8.5. DATABRIDGE ANALYSIS 14.9 VITALOGRAPH 14.9.1. COMPANY OVERVIEW 14.9.2. FINANCIAL ANALYSIS 14.9.3. PRODUCT MATRIX 14.9.4. RECENT DEVELOPMENTS 14.9.5. DATABRIDGE ANALYSIS   14.10 NDD MEDIZINTECHNIK AG 14.10.1. COMPANY OVERVIEW 14.10.2. FINANCIAL ANALYSIS 14.10.3. PRODUCT MATRIX 14.10.4. RECENT DEVELOPMENTS 14.10.5. DATABRIDGE ANALYSIS 14.11 SCHILLER 14.11.1. COMPANY OVERVIEW 14.11.2. FINANCIAL ANALYSIS 14.11.3. PRODUCT MATRIX 14.11.4. RECENT DEVELOPMENTS 14.11.5. DATABRIDGE ANALYSIS 14.12 JONES MEDICAL INSTRUMENT COMPANY 14.12.1. COMPANY OVERVIEW 14.12.2. FINANCIAL ANALYSIS 14.12.3. PRODUCT MATRIX 14.12.4. RECENT DEVELOPMENTS 14.12.5. DATABRIDGE ANALYSIS 14.13 SDI DIAGNOSTICS 14.13.1. COMPANY OVERVIEW 14.13.2. FINANCIAL ANALYSIS 14.13.3. PRODUCT MATRIX 14.13.4. RECENT DEVELOPMENTS 14.13.5. DATABRIDGE ANALYSIS   14.14 GERATHERN RESPIRATORY GMBH 14.14.1. COMPANY OVERVIEW 14.14.2. FINANCIAL ANALYSIS 14.14.3. PRODUCT MATRIX 14.14.4. RECENT DEVELOPMENTS 14.14.5. DATABRIDGE ANALYSIS 14.15 THOR 14.15.1. COMPANY OVERVIEW 14.15.2. FINANCIAL ANALYSIS 14.15.3. PRODUCT MATRIX 14.15.4. RECENT DEVELOPMENTS 14.15.5. DATABRIDGE ANALYSIS 14.16 FUKUDA SANGYO INC. 14.16.1. COMPANY OVERVIEW 14.16.2. FINANCIAL ANALYSIS 14.16.3. PRODUCT MATRIX 14.16.4. RECENT DEVELOPMENTS 14.16.5. DATABRIDGE ANALYSIS 14.17 CONTEC MEDICAL SYSTEMS CO., LTD. 14.17.1. COMPANY OVERVIEW 14.17.2. FINANCIAL ANALYSIS 14.17.3. PRODUCT MATRIX 14.17.4. RECENT DEVELOPMENTS 14.17.5. DATABRIDGE ANALYSIS   14.18 KONINKLIJKE PHILIPS N.V. 14.18.1. COMPANY OVERVIEW 14.18.2. FINANCIAL ANALYSIS 14.18.3. PRODUCT MATRIX 14.18.4. RECENT DEVELOPMENTS 14.18.5. DATABRIDGE ANALYSIS 14.19 BD 14.19.1. COMPANY OVERVIEW 14.19.2. FINANCIAL ANALYSIS 14.19.3. PRODUCT MATRIX 14.19.4. RECENT DEVELOPMENTS 14.19.5. DATABRIDGE ANALYSIS 14.20 CARDIOTECH 14.20.1. COMPANY OVERVIEW 14.20.2. FINANCIAL ANALYSIS 14.20.3. PRODUCT MATRIX 14.20.4. RECENT DEVELOPMENTS 14.20.5. DATABRIDGE ANALYSIS 15 APPENDIX 16 ABOUT DATA BRIDGE MARKET RESEARCH  

• BD, • Midmark Corp • Welch allyn • SDI Diagnostics, • Geratherm Respiratory GMBH,